NCT04319198 Rollover Study in Participants With Metastatic Solid Tumors Benefiting From Therapy With Sacituzumab Govitecan-hziy Status COMPLETED Phase PHASE4
NCT04313881 Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS) Status TERMINATED Phase PHASE3
NCT04296695 Biktarvy in Treatment-Naïve Late Presenters With HIV-1 Infection Status COMPLETED Phase PHASE4
NCT04292899 Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) Status COMPLETED Phase PHASE3
NCT04292730 Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment Status COMPLETED Phase PHASE3
NCT04286347 HCV, HBV, HIV Testing During Consultation With Anesthesiologist Status TERMINATED Phase NA
NCT04262856 Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT04251416 A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04249037 Rapid Start vs. Standard Start Antiretroviral Therapy (ART) in HIV Status TERMINATED Phase PHASE4
NCT04240691 Instacare - Rapid ART Initiation Among Persons With HIV and Out of Care Status COMPLETED Phase N/A
NCT04226131 MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics Status COMPLETED Phase NA
NCT04211909 Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir (SOF/VEL) Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX ) FDC for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection Status COMPLETED Phase PHASE3
NCT04150068 Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT04143594 Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Agents in People Living With HIV Status COMPLETED Phase PHASE2
NCT04130919 Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative Colitis Status TERMINATED Phase PHASE2
NCT04115839 Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy Status TERMINATED Phase PHASE3
NCT04115748 Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy Status TERMINATED Phase PHASE3